CRH Management Team
CRH Medical Corporation is led by an experienced, passionate team of executives:
Edward Wright - Chief Executive Officer, DirectorMr. Wright became Chief Executive Officer and a member of the Board of Directors of CRH Medical Corporation in September 2006.
Prior to joining CRH Medical, Mr. Wright worked for Richemont, owner of several of the world's leading companies in the field of luxury goods, as President of Baume & Mercier North America and then as Senior Vice President of Retail for Cartier North America until August 2006.
Upon arriving at CRH, Mr. Wright set out to maximize the value of CRH’s O’Regan System and was instrumental in its introduction to Gastroenterologists in the United States, thereby creating a paradigm shift in the treatment of hemorrhoids within the Gastroenterology community. The CRH O’Regan System’s direct-to-physician model has extended the continuum of care for Gastroenterologists’ patients.
Mr. Wright directed a strategic business review that, in December 2014, culminated in the launch of CRH Anesthesia Management, a business that provides gastrointestinal (“GI”) anesthesia services to ambulatory surgical centers across the US. CRH Anesthesia has become one of the leading GI anesthesia companies in the US with the goal of becoming the nation’s pre-eminent provider of GI anesthesia. Under Mr. Wright’s direction, CRH has become a profitable company with strong cash flow generation.
In 2015, Mr. Wright was recognized as British Columbia’s CEO of the year in the small-medium public company category. He is a member of the Young Presidents’ Organization and Chair of the Board at Vancouver College.
Richard Bear - Chief Financial OfficerMr. Bear has been an Officer of the company since March of 2006.
Prior to joining CRH, Mr. Bear worked at ID Biomedical Corporation as Chief Financial Officer until 2006, when the company was acquired by GlaxoSmithKline.
Since joining CRH, Mr. Bear has planned and executed all of our financial transactions including capital private placement, debt issuance and restructuring, establishment and extension of our existing credit facility with US and Canadian financial institutions, and listing of our shares on the NYSE Market.
Since December of 2014, Mr. Bear has also been involved in the negotiation of CRH Anesthesia’s acquisition. He is responsible for acquisition financing, as well as the accounting and financial integration of CRH Anesthesia Management’s acquisitions into our organization.
Mr. Bear has a degree in Business Administration from the University of Washington and has received a Certified Public Accountant (CPA) designation.
Mitchel Guttenplan, MD, FACS - Medical DirectorDr. Guttenplan joined CRH Medical in 2006 as the Co-Medical Director of the Centers for Colorectal Health in Metropolitan Atlanta. He became Medical Director of CRH in 2008, when the company migrated the O’Regan System to a direct-to-physician business model.
In his role as Medical Director at CRH, Dr. Guttenplan designed and implemented the O’Regan training program and to date he has trained thousands of gastroenterologists and surgeons in the United States and Internationally in the use of CRH’s O'Regan System.
Dr. Guttenplan is considered one of the foremost experts in hemorrhoid banding in the US and has been a guest lecturer at numerous medical schools, hospitals and GI societies, as well as regional and national scientific meetings. He has also authored a number of white papers, articles and an upcoming textbook chapter discussing the treatment of perianal diseases for medical publications.
He graduated from the Emory University School of Medicine and completed his residency in General Surgery at the Emory University Affiliated Hospitals. Dr. Guttenplan has been a practicing Board Certified general surgeon since 1987.